Clinical Trials Browser

Phase 2 × Neoplasms × Idarubicin × Clear all

NCT01035502 2013-09-27

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Phase 2 Completed

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute